GLP-1, Weight Loss Drugs, Ozempic, Obesity, NMDA Receptors, Metabolism & Brain Health | Christoffer Clemmensen | Episode 161

Send us Fan Mail

About the guest: Christoffer Clemmensen, PhD is scientist running the Metabolism & Molecular Pharmacology group at the University of Copenhagen in Denmark. His lab studies the biological basis of obesity & other metabolic disorders.

Episode summary: Nick and Dr. Clemmensen discuss: GLP-1 & gut hormones; obesity & metabolic disease; GLP-1 agonists and weight loss drugs (e.g. Ozempic); novel, dual-action weight loss drugs his lab has created; and more.

Previous discussion: Metabolism, Obesity & Psychedelics for Metabolic Disease | Christoffer Clemmensen | #105

*This content is never meant to serve as medical advice.

Support the show

Support my work:

• Good Chemistry: Personalized, science-based health consulting. Work with Dr. Nick Jikomes directly.
• Affiliate Partners: Visit this link to see my affiliate partners and get discounts codes for products & services to support health.

For all the ways you can support my efforts.